{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T02:25:53Z","timestamp":1787192753714,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Undergraduate Scientific Research Training Program of Army Medical University","award":["2025XBK40"],"award-info":[{"award-number":["2025XBK40"]}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2023NSCQ-MSX0956"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0956"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05000-3","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:03:01Z","timestamp":1781485381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Short-chain fatty acids of intestinal origin attenuate protein-bound uremic toxins in patients with chronic kidney disease by protecting the intestinal barrier: a pooled analysis of multiple studies with individualized intervention strategies"],"prefix":"10.1186","volume":"26","author":[{"given":"Mengzhe","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingge","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"12","key":"5000_CR1","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","volume":"69","author":"X Wang","year":"2020","unstructured":"Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J, Zhang L, Zhang C, Bian W, Zuo L, et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut. 2020;69(12):2131\u201342.","journal-title":"Gut"},{"issue":"10","key":"5000_CR2","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.chom.2025.08.014","volume":"33","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Han X, Feng T, Li Z, Yu H, Chen Y, Gao Y, Gao Q, Zhang L, Li S, et al. Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease. Cell Host Microbe. 2025;33(10):1715\u2013e17301715.","journal-title":"Cell Host Microbe"},{"issue":"10","key":"5000_CR3","doi-asserted-by":"publisher","first-page":"114830","DOI":"10.1016\/j.celrep.2024.114830","volume":"43","author":"ZL Si","year":"2024","unstructured":"Si ZL, Wang HY, Wang T, Cao YZ, Li QZ, Liu K, Huang Z, Liu HL, Tan YJ, Wang YY, et al. Gut Bacteroides ovatus ameliorates renal fibrosis by promoting the production of HDCA through upregulation of Clostridium scindens. Cell Rep. 2024;43(10):114830.","journal-title":"Cell Rep"},{"issue":"9","key":"5000_CR4","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1161\/CIRCRESAHA.122.320184","volume":"131","author":"HB Li","year":"2022","unstructured":"Li HB, Xu ML, Xu XD, Tang YY, Jiang HL, Li L, Xia WJ, Cui N, Bai J, Dai ZM, et al. Faecalibacterium prausnitzii Attenuates CKD via Butyrate-Renal GPR43 Axis. Circ Res. 2022;131(9):e120\u201334.","journal-title":"Circ Res"},{"issue":"1","key":"5000_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s40168-022-01390-0","volume":"10","author":"J Yan","year":"2022","unstructured":"Yan J, Pan Y, Shao W, Wang C, Wang R, He Y, Zhang M, Wang Y, Li T, Wang Z, et al. Beneficial effect of the short-chain fatty acid propionate on vascular calcification through intestinal microbiota remodelling. Microbiome. 2022;10(1):195.","journal-title":"Microbiome"},{"issue":"3","key":"5000_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.kint.2025.06.004","volume":"108","author":"LA Raillon","year":"2025","unstructured":"Raillon LA, Florens N, Payelle F, Martin M, Soul\u00e8re L, Yi D, Simon-Onfroy Z, Chambert S, Legras M, Chardon L, et al. Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis. Kidney Int. 2025;108(3):411\u201326.","journal-title":"Kidney Int"},{"key":"5000_CR7","doi-asserted-by":"crossref","unstructured":"Allaoui BE, Wu X, Wu T, Pang CH. Advanced Functional Materials in Kidney Dialysis: Progress, Challenges, and Clinical Prospects. Adv Healthc Mater. 2026;15(12):e03904.","DOI":"10.1002\/adhm.202503904"},{"key":"5000_CR8","doi-asserted-by":"crossref","unstructured":"Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets. Toxins (Basel). 2021;13(2):142.","DOI":"10.3390\/toxins13020142"},{"key":"5000_CR9","doi-asserted-by":"crossref","unstructured":"Steenbeke M, Valkenburg S, Gryp T, Van Biesen W, Delanghe JR, Speeckaert MM, Glorieux G. Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease. Toxins (Basel). 2021;13(11):809.","DOI":"10.3390\/toxins13110809"},{"issue":"4","key":"5000_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/ajcn\/nqac175","volume":"116","author":"B Seethaler","year":"2022","unstructured":"Seethaler B, Nguyen NK, Basrai M, Kiechle M, Walter J, Delzenne NM, Bischoff SC. Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial. Am J Clin Nutr. 2022;116(4):928\u201342.","journal-title":"Am J Clin Nutr"},{"key":"5000_CR11","doi-asserted-by":"crossref","unstructured":"Vaduganathan M, Green JB, Heerspink HJL, Kim SG, Mann JFE, McGill JB, Mottl A, Nangaku M, Rosenstock J, Rossing P et al. Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial. Nephrol Dial Transpl. 2025.","DOI":"10.1093\/ndt\/gfaf160"},{"key":"5000_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.aninu.2021.11.005","volume":"8","author":"M Akhtar","year":"2022","unstructured":"Akhtar M, Chen Y, Ma Z, Zhang X, Shi D, Khan JA, Liu H. Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation. Anim Nutr. 2022;8:350\u201360.","journal-title":"Anim Nutr"},{"key":"5000_CR13","doi-asserted-by":"publisher","first-page":"650313","DOI":"10.3389\/fphys.2021.650313","volume":"12","author":"D P\u00e9rez-Reytor","year":"2021","unstructured":"P\u00e9rez-Reytor D, Puebla C, Karahanian E, Garc\u00eda K. Use of Short-Chain Fatty Acids for the Recovery of the Intestinal Epithelial Barrier Affected by Bacterial Toxins. Front Physiol. 2021;12:650313.","journal-title":"Front Physiol"},{"issue":"1","key":"5000_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s10020-023-00745-z","volume":"29","author":"L Ma","year":"2023","unstructured":"Ma L, Zhang L, Li J, Zhang X, Xie Y, Li X, Yang B, Yang H. The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease. Mol Med. 2023;29(1):148.","journal-title":"Mol Med"},{"issue":"1","key":"5000_CR15","doi-asserted-by":"publisher","first-page":"36274","DOI":"10.1038\/s41598-025-20266-5","volume":"15","author":"S Udomkarnjananun","year":"2025","unstructured":"Udomkarnjananun S, Chuaypen N, Metta K, Dissayabutra T, Sodsai P, Kittiskulnam P, Tangkijvanich P. Dietary composition modulate gut microbiota and related biomarkers in patients with chronic kidney disease. Sci Rep. 2025;15(1):36274.","journal-title":"Sci Rep"},{"key":"5000_CR16","doi-asserted-by":"crossref","unstructured":"Wu IW, Lee CC, Hsu HJ, Sun CY, Chen YC, Yang KJ, Yang CW, Chung WH, Lai HC, Chang LC et al. Compositional and Functional Adaptations of Intestinal Microbiota and Related Metabolites in CKD Patients Receiving Dietary Protein Restriction. Nutrients. 2020;12(9):2799.","DOI":"10.3390\/nu12092799"},{"key":"5000_CR17","doi-asserted-by":"crossref","unstructured":"L\u00facio HG, Lopes R, Gomes MJC, da Silva A, Grancieri M, Della Lucia CM, Queiroz VAV, da Silva BP, Martino HSD. A Symbiotic Meal Containing Extruded Sorghum and Probiotic (Bifidobacterium longum) Ameliorated Intestinal Health Markers in Individuals with Chronic Kidney Disease: A Secondary Analysis of a Subsample from a Previous Randomized and Controlled Clinical Trial. Nutrients. 2024;16(12):1852.","DOI":"10.3390\/nu16121852"},{"issue":"8","key":"5000_CR18","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1136\/gutjnl-2019-319188","volume":"69","author":"PP Erawijantari","year":"2020","unstructured":"Erawijantari PP, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Saito Y, Fukuda S, Yachida S, Yamada T. Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles. Gut. 2020;69(8):1404\u201315.","journal-title":"Gut"},{"issue":"8","key":"5000_CR19","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/gutjnl-2017-314759","volume":"67","author":"BR Stevens","year":"2018","unstructured":"Stevens BR, Goel R, Seungbum K, Richards EM, Holbert RC, Pepine CJ, Raizada MK. Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression. Gut. 2018;67(8):1555\u20137.","journal-title":"Gut"},{"key":"5000_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"5000_CR21","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.apsb.2022.12.010","volume":"13","author":"L Pan","year":"2023","unstructured":"Pan L, Yu H, Fu J, Hu J, Xu H, Zhang Z, Bu M, Yang X, Zhang H, Lu J, et al. Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota. Acta Pharm Sin B. 2023;13(4):1537\u201353.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"5000_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13073-021-00921-y","volume":"13","author":"W Ma","year":"2021","unstructured":"Ma W, Nguyen LH, Song M, Wang DD, Franzosa EA, Cao Y, Joshi A, Drew DA, Mehta R, Ivey KL, et al. Dietary fiber intake, the gut microbiome, and chronic systemic inflammation in a cohort of adult men. Genome Med. 2021;13(1):102.","journal-title":"Genome Med"},{"issue":"6","key":"5000_CR23","doi-asserted-by":"publisher","first-page":"106979","DOI":"10.1016\/j.isci.2023.106979","volume":"26","author":"H Wu","year":"2023","unstructured":"Wu H, Wu Z, Qiu Y, Zhao F, Liao M, Zhong Z, Chen J, Zeng Y, Liu R. Supplementing a specific synbiotic suppressed the incidence of AOM\/DSS-induced colorectal cancer in mice. iScience. 2023;26(6):106979.","journal-title":"iScience"},{"key":"5000_CR24","doi-asserted-by":"crossref","unstructured":"Magliocca G, Mone P, Di Iorio BR, Heidland A, Marzocco S. Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation. Int J Mol Sci. 2022;23(10):5354.","DOI":"10.3390\/ijms23105354"},{"issue":"1","key":"5000_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/ndt\/gfae118","volume":"40","author":"V Corte-Iglesias","year":"2024","unstructured":"Corte-Iglesias V, Saiz ML, Andrade-Lopez AC, Salazar N, Bernet CR, Martin-Martin C, Borra JM, Lozano JJ, Aransay AM, Diaz-Corte C, et al. Propionate and butyrate counteract renal damage and progression to chronic kidney disease. Nephrol Dial Transpl. 2024;40(1):133\u201350.","journal-title":"Nephrol Dial Transpl"},{"key":"5000_CR26","doi-asserted-by":"publisher","first-page":"1660226","DOI":"10.3389\/fimmu.2025.1660226","volume":"16","author":"C Liu","year":"2025","unstructured":"Liu C, Wang J, Lei L, Li L, Yuan X. Gut microbiota therapy for chronic kidney disease. Front Immunol. 2025;16:1660226.","journal-title":"Front Immunol"},{"key":"5000_CR27","doi-asserted-by":"crossref","unstructured":"Szrejder M, Piwkowska A. Gut Microbiome-Derived Short-Chain Fatty Acids in Glomerular Protection and Modulation of Chronic Kidney Disease Progression. Nutrients. 2025;17(17):2904.","DOI":"10.3390\/nu17172904"},{"issue":"10","key":"5000_CR28","first-page":"Cd013631","volume":"10","author":"TE Cooper","year":"2023","unstructured":"Cooper TE, Khalid R, Chan S, Craig JC, Hawley CM, Howell M, Johnson DW, Jaure A, Teixeira-Pinto A, Wong G. Synbiotics, prebiotics and probiotics for people with chronic kidney disease. Cochrane Database Syst Rev. 2023;10(10):Cd013631.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05000-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05000-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05000-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T02:17:27Z","timestamp":1787192247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05000-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5000"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05000-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is a multicenter integrative analysis based on previously published clinical studies (detailed in the References section). All included original studies have obtained ethical approval from their respective institutional review boards or ethics committees, and all participants provided written informed consent prior to their enrollment in accordance with the Declaration of Helsinki. For the present integrative analysis, we used de-identified secondary data extracted from publicly available literature, without direct involvement of human subjects or access to identifiable personal information. Therefore, additional ethical approval and consent to participate are not required for this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"514"}}